Male birth control shot moves closer to reality
NCT ID NCT02927210
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 32 times
Summary
This early-stage study tested a single injection of a hormone-based drug called DMAU in 106 healthy men to see if it is safe and tolerable as a potential male contraceptive. The drug aims to temporarily lower sperm production without affecting sexual function or mood. The study focused on safety and how the body processes the drug, not on preventing pregnancy directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, 90509, United States
-
University of Washington Medical Center & Health Sciences
Seattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.